Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • Equities
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Macro Notification
  • Management
  • Market Summary
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Mining
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week
Browsing Category

Movers

Group By Ticker
Sort By
Newest | Oldest
Read More
1 minute read
  • General
  • Health Care
  • Movers
  • News
  • Penny Stocks
  • Trading Ideas

Why iSpecimen Shares Are Gaining Today?

By Vandana Singh
July 7, 11:03 AM
iSpecimen Inc (NASDAQ:ISPC) has added new global biospecimen suppliers to its proprietary Marketplace platform for advancing oncology and cardiovascular disease research.…

ISPC

Read More
2 minute read
  • Markets
  • Movers
  • Trading Ideas

Will Chart Analysts Notice Bad Omen on Welltower OP’s Chart

By Benzinga Insights
July 7, 11:00 AM
If history is any guide, there may be trouble ahead for shares of Welltower OP (NYSE:WELL). A so-called "death cross" has formed on its chart and, not surprisingly, this could be bearish for the stock.

WELL

Read More
1 minute read
  • Markets
  • Movers
  • Trading Ideas

This Foreboding Sign Looms Over TELUS’s Chart

By Benzinga Insights
July 7, 11:00 AM
If history is any guide, there may be trouble ahead for shares of TELUS (NYSE:TU). A so-called "death cross" has formed on its chart and, not surprisingly, this could be bearish for the stock. What To Know: Many traders use moving average crossover systems to make their decisions.

TU

Read More
1 minute read
  • Markets
  • Movers
  • Trading Ideas

Will Chart Analysts Notice Bad Omen on Everest Re Group’s Chart

By Benzinga Insights
July 7, 11:00 AM
If history is any guide, there may be trouble ahead for shares of Everest Re Group (NYSE:RE). A so-called "death cross" has formed on its chart and, not surprisingly, this could be bearish for the stock.

RE

Read More
1 minute read
  • Markets
  • Movers
  • Trading Ideas

Death Cross Looms Over Rogers Communications Investors

By Benzinga Insights
July 7, 11:00 AM
If history is any guide, there may be trouble ahead for shares of Rogers Communications (NYSE:RCI). A so-called "death cross" has formed on its chart and, not surprisingly, this could be bearish for the stock.

RCI

Read More
1 minute read
  • Markets
  • Movers
  • Trading Ideas

Ominous Death Cross Forms On MPLX’s Chart

By Benzinga Insights
July 7, 10:59 AM
If history is any guide, there may be trouble ahead for shares of MPLX (NYSE:MPLX). A so-called "death cross" has formed on its chart and, not surprisingly, this could be bearish for the stock.

MPLX

Read More
1 minute read
  • Markets
  • Movers
  • Trading Ideas

Death Cross Looms Over Brookfield Infr Partners Investors

By Benzinga Insights
July 7, 10:59 AM
If history is any guide, there may be trouble ahead for shares of Brookfield Infr Partners (NYSE:BIP). A so-called "death cross" has formed on its chart and, not surprisingly, this could be bearish for the stock.

BIP

Read More
3 minute read
  • Biotech
  • Contracts
  • FDA
  • General
  • Health Care
  • Insider Trades
  • M&A
  • Movers
  • News
  • Penny Stocks
  • Rumors
  • Small Cap
  • Stock Split
  • Trading Ideas

The Daily Biotech Pulse: Merck’s Seagen Buyout Advances, Adverum Restructures, Pharmacists Get OK To Prescribe Pfizer COVID-19 Pill

By Vandana Singh
July 7, 10:03 AM
Here's a roundup of top developments in the biotech space over the last 24 hours:

ADVM

Read More
1 minute read
  • M&A
  • Movers
  • Trading Ideas

Why Merck Is Sending Seagen Stock Higher Today

By Adam Eckert
July 7, 9:15 AM
Seagen Inc (NASDAQ: SGEN) shares are trading higher Thursday following reports suggesting Merck & Company Inc (NYSE: MRK) is in advanced talks to acquire the company.

MRK

Read More
1 minute read
  • Biotech
  • Earnings
  • General
  • Health Care
  • Movers
  • News
  • Penny Stocks
  • Trading Ideas

Adverum Biotechnologies Cuts Workforce, Prioritizes ADVM-022

By Vandana Singh
July 7, 8:02 AM
Adverum Biotechnologies Inc (NASDAQ:ADVM) announced a restructuring plan, including reductions in headcount and expenses, to prioritize its clinical development of…

ADVM

Posts pagination

Previous 1 … 2,337 2,338 2,339 … 2,348 Next
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service